Rotavirus and biliary atresia: Can causation be proven?

Current Opinion in Gastroenterology

Volumn 28, Issue 1, 2012, Pages 10-17

  Hertel, Paula M ^a   Estes, Mary K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Biliary atresia; Impact of vaccination; Rotavirus

Indexed keywords

CYTOKINE; ROTAVIRUS VACCINE;

BILE DUCT ATRESIA; DIARRHEA; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; HEALTH PROGRAM; HUMAN; INFLAMMATION; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; ROTAVIRUS; ROTAVIRUS INFECTION; T LYMPHOCYTE; VIRUS GENE;

ANIMALS; BILE DUCTS; BILIARY ATRESIA; HUMANS; INCIDENCE; INFANT; RISK FACTORS; ROTAVIRUS; ROTAVIRUS INFECTIONS; WORLD HEALTH;

EID: 84857058561     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32834c7ae4     Document Type: Review

References (49)

1. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis 2007; 27:233-242. (Pubitemid 47301763)
2. Mack CL, Tucker RM, Lu BR, et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006; 44:1231-1239. (Pubitemid 44748373)
3. Shivakumar P, Campbell KM, Sabla GE, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004; 114:322-329. (Pubitemid 39071604)
4. Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009; 136:1939-1951.
5. McNeal MM, Belli J, Basu M, et al. Discovery of a new strain of murine rotavirus that is consistently shed in large quantities after oral inoculation of adult mice. Virology 2004; 320:1-11. (Pubitemid 38296710)
6. Blutt SE, Kirkwood CD, Parreno V, et al. Rotavirus antigenaemia and viraemia: a common event? Lancet 2003; 362:1445-1449. (Pubitemid 37352880)
7. Blutt SE, Matson DO, Crawford SE, et al. Rotavirus antigenemia in children is associated with viremia. PLoS Med 2007; 4:e121.
8. Blutt SE, Conner ME. Rotavirus: to the gut and beyond! Curr Opin Gastroenterol 2007; 23:39-43. (Pubitemid 44875908)
9. Ramani S, Paul A, Saravanabavan A, et al. Rotavirus antigenemia in Indian children with rotavirus gastroenteritis and asymptomatic infections. Clin Infect Dis 2010; 51:1284-1289.
10. Ramig RF. Systemic rotavirus infection. Expert Rev Anti Infect Ther 2007; 5:591-612. (Pubitemid 47250133)
11. Patel M, Rench MA, Boom JA, et al. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J 2010; 29:836-839.
12. Sugata K, Taniguchi K, Yui A, et al. Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics 2008; 122:392-397.
13. Chitambar SD, Tatte VS, Dhongde R, et al. High frequency of rotavirus viremia in children with acute gastroenteritis: discordance of strains detected in stool and sera. J Med Virol 2008; 80:2169-2176.
14. Fischer TK, Ashley D, Kerin T, et al. Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis 2005; 192:913-919. (Pubitemid 41193090)
15. Hertel PM, Crawford SE, Finegold MJ, et al. Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia. Virology 2011; 417:281-292. This study demonstrates rotavirus antigenemia in the biliary atresia mouse model and shows that osteopontin, a molecule with cytokine properties previously suggested to play a role in biliary atresia pathogenesis, is not required for disease.
16. Mack CL, Tucker RM, Sokol RJ, et al. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 2005; 115:200-209. (Pubitemid 40693091)
17. Riepenhoff-Talty M, Schaekel K, Clark HF, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993; 33 (4 Pt 1):394-399. (Pubitemid 23095773)
18. Petersen C, Kuske M, Bruns E, et al. Progress in developing animal models for biliary atresia. Eur J Pediatr Surg 1998; 8:137-141. (Pubitemid 28312048)
19. Feng N, Sen A, Wolf M, et al. Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract. J Virol 2011; 85:2686-2694.
20. Wang W, Donnelly B, Bondoc A, et al. The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice. J Virol 2011; 85:9069-9077. This study utilizes reassortant rotaviruses to determine that rotavirus gene 4 is required for cholangiocyte infection and induction of biliary atresia in the mouse model.
21. Allen SR, Jafri M, Donnelly B, et al. Effect of rotavirus strain on the murine model of biliary atresia. J Virol 2007; 81:1671-1679. (Pubitemid 46214442)
22. Feng N, Kim B, Fenaux M, et al. Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol 2008; 82:7578-7590. (Pubitemid 352031225)
23. Riepenhoff-Talty M, Gouvea V, Evans MJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996; 174:8-15. (Pubitemid 26255549)
24. Qiao H, Clark HF, DiVietro M, et al. A comparison of the effects of oral inoculation with Rotashield and pentavalent reassortant rotavirus vaccine (WC3-PV) on suckling CB17scid mice. J Gen Virol 2004; 85 (Pt 8):2245-2253. (Pubitemid 39162597)
25. Uhnoo I, Riepenhoff-Talty M, Dharakul T, et al. Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol 1990; 64:361-368. (Pubitemid 20032636)
26. Baker M, Prasad BV. Rotavirus cell entry. Curr Top Microbiol Immunol 2010; 343:121-148.
27. Fleming FE, Graham KL, Takada Y, et al. Determinants of the specificity of rotavirus interactions with the alpha2beta1 integrin. J Biol Chem 2011; 286:6165-6174.
28. Jafri M, Donnelly B, Allen S, et al. Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol 2008; 295:G16-G26.
29. Czech-Schmidt G, Verhagen W, Szavay P, et al. Immunological gap in the infectious animal model for biliary atresia. J Surg Res 2001; 101:62-67. (Pubitemid 33030108)
30. Shivakumar P, Sabla GE, Whitington P, et al. Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest 2009; 119:2281-2290.
31. Miethke AG, Saxena V, Shivakumar P, et al. Postnatal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia. J Hepatol 2010; 52:718-726. This study determines that adoptive transfer of CD4+ lymphocytes including Tregs leads to improved survival in the biliary atresia mouse model and hypothesizes that a relative deficiency of Tregs in neonatal mice may contribute to the neonate's susceptibility to biliary atresia.
32. Kuebler JF, Czech-Schmidt G, Leonhardt J, et al. Type-I but not type-II interferon receptor knockout mice are susceptible to biliary atresia. Pediatr Res 2006; 59:790-794. (Pubitemid 44297630)
33. Shivakumar P, Sabla G, Mohanty S, et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007; 133:268-277. (Pubitemid 47031130)
34. Tucker RM, Hendrickson RJ, Mukaida N, et al. Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol 2007; 20:34-43. (Pubitemid 46608950)
35. Mohanty SK, Shivakumar P, Sabla G, et al. Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol 2006; 6:14.
36. Bessho K, Bezerra JA. Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med 2011; 62:171-185.
37. Petersen C. Pathogenesis and treatment opportunities for biliary atresia. Clin Liver Dis 2006; 10:73-88; vi.
38. Lu BR, Brindley SM, Tucker RM, et al. Alpha-enolase autoantibodies crossreactive to viral proteins in a mouse model of biliary atresia. Gastroenterology 2010; 139:1753-1761. This study uses the biliary atresia mouse model to identify autoantibodies to the cholangiocyte protein enolase that cross-react with rotavirus VP4 and hypothesizes a mechanism of molecular mimicry in immune-mediated biliary damage in biliary atresia.
39. Finkbeiner SR, Holtz LR, Jiang Y, et al. Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J 2009; 6:161.
40. Finkbeiner SR, Allred AF, Tarr PI, et al. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog 2008; 4:e1000011.
41. Paulke-Korinek M, Kundi M, Rendi-Wagner P, et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29:2791-2796.
42. Patel MM, Steele D, Gentsch JR, et al. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011; 30 (1 Suppl):S1-S5. This review summarizes the effects of rotavirus vaccination programs worldwide to date and discusses the importance of continuing evaluation of these programs.
43. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011; 30 (1 Suppl):S56-S60.
44. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009; 19:231-234.
45. Englund JA, Mbawuike IN, Hammill H, et al. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993; 168:647-656. (Pubitemid 23254284)
46. Turowski C, Leonhardt J, Teichmann B, et al. Preconceptional oral vaccination prevents experimental biliary atresia in newborn mice. Eur J Pediatr Surg 2010; 20:158-163.
47. Bondoc AJ, Jafri MA, Donnelly B, et al. Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. J Pediatr Surg 2009; 44:1479-1490.
48. Marcelin G, Miller AD, Blutt SE, et al. Immune mediators of rotavirus antigenemia clearance in mice. J Virol 2011; 85:7937-7941.
49. Gladstone BP, Ramani S, Mukhopadhya I, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 2011; 365:337-346.